Related Articles
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
BIIB021, an Hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review)
Effects of treatment with an Hsp90 inhibitor in tumors based on 15 phase II clinical trials
Preclinical antitumor activity of SST0116CL1: A novel heat shock protein 90 inhibitor
HSP90 and its inhibitors (Review)